| 1 | Overlapping Presentations and Diverse Genetic Defects Characterize Neuroendocrine Neoplasms in a Mexican Cohort | Coautor: Sosa-Eroza E., Hernández-Ramírez L.C., Ramírez-Rentería C., Rebollar-Vega R.G., et al. | 2025 | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | WoS-id: 001427130900001
Scopus-id: 2-s2.0-105016704570
| 2 | 2 |
| 2 | Efficiency and Safety of CyberKnife Robotic Radiosurgery in the Multimodal Management of Patients with Acromegaly | Coautor: Sosa-Eroza E., Romero-Gameros C.A., González-Virla B., Vargas-Ortega G., et al. | 2023 | Cancers | WoS-id: 000947599200001
Scopus-id: 2-s2.0-85149814844
| 6 | 6 |
| 3 | The kinome, cyclins and cyclin-dependent kinases of pituitary adenomas, a look into the gene expression profile among tumors from different lineages | Coautor: SOSA, ERNESTO, Taniguchi-Ponciano, Keiko, Portocarrero-Ortiz, Lesly A., GUINTO, GERARDO, et al. | 2022 | BMC MEDICAL GENOMICS | WoS-id: 000766171900001
Scopus-id: 2-s2.0-85126079753
| 11 | 11 |
| 4 | Response to Letter to the Editor: ?High biochemical recurrence rate after withdrawal of cabergoline in prolactinomas: is it necessary to restart treatment?? | Coautor: Sosa-Eroza E., Espinosa-Cárdenas E., Sánchez-García M., Ramírez-Rentería C., et al. | 2021 | ENDOCRINE | WoS-id: 000609355100002
Scopus-id: 2-s2.0-85099863651
| 0 | 0 |
| 5 | Risk factors associated with thyroid nodular disease in acromegalic patients: A case-cohort study in a tertiary center | Coautor: Sosa-Eroza E., Vargas-Ortega G., Romero-Gameros C.A., Rendón-Macias M.E., et al. | 2021 | GROWTH HORMONE & IGF RESEARCH | WoS-id: 000719441100016
Scopus-id: 2-s2.0-85118320112
| 10 | 7 |
| 6 | Are there really any predictive factors for a successful weight loss after bariatric surgery? | Coautor: Sosa-Eroza E., Cadena-Obando D., Ramírez-Rentería C., Ferreira-Hermosillo A., et al. | 2020 | BMC ENDOCRINE DISORDERS | WoS-id: 000513547600001
Scopus-id: 2-s2.0-85079035890
| 116 | 118 |
| 7 | Molecular alterations in non-functioning pituitary adenomas | Coautor: Sosa, Ernesto, Taniguchi-Ponciano, Keiko, Gomez-Apo, Erick, Chavez-Macias, Laura, et al. | 2020 | CANCER BIOMARKERS | WoS-id: 000569158000007
Scopus-id: 2-s2.0-85086052104
| 9 | 10 |
| 8 | Proteomic and transcriptomic analysis identify spliceosome as a significant component of the molecular machinery in the pituitary tumors derived from POU1F1-and NR5A1-cell lineages | Coautor: Sosa E., Taniguchi-Ponciano K., Peña-Martínez E., Silva-Román G., et al. | 2020 | GENES | WoS-id: 000601943000001
Scopus-id: 2-s2.0-85097037546
| 11 | 9 |
| 9 | Treatment of multiresistant prolactinomas with a combination of cabergoline and octreotide LAR | 1ᵉʳ autor: Sosa-Eroza E., Espinosa E., Ramírez-Rentería C., Mendoza V., et al. | 2018 | ENDOCRINE | WoS-id: 000438994200022
Scopus-id: 2-s2.0-85048362060
| 37 | 35 |
| 10 | Prevalence, Clinical and Biochemical Spectrum, and Treatment Outcome of Acromegaly With Normal Basal GH at Diagnosis | 2ᵒ autor: Sosa-Eroza E., Espinosa de Los Monteros A.L., Gonzalez B., Mendoza V., et al. | 2018 | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | WoS-id: 000448258100038
Scopus-id: 2-s2.0-85054422816
| 17 | 20 |
| 11 | Long-term outcome of the different treatment alternatives for recurrent and persistent cushing disease | 2ᵒ autor: Sosa-Eroza E., Espinosa-De-Los-Monteros A.L., Espinosa E., Mendoza V., et al. | 2017 | ENDOCRINE PRACTICE | WoS-id: 000411113000001
Scopus-id: 2-s2.0-85026293521
| 23 | 25 |
| 12 | Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas | 2ᵒ autor: Sosa E., Shimon I., Mendoza V., Greenman Y., et al. | 2016 | Pituitary | WoS-id: 000379350000012
Scopus-id: 2-s2.0-84965003749
| 58 | 69 |
| 13 | AIP mutations in young patients with acromegaly and the Tampico Giant: the Mexican experience | Coautor: Sosa E., Ramírez-Rentería C., Hernández-Ramírez L.C., Portocarrero-Ortiz L., et al. | 2016 | ENDOCRINE | WoS-id: 000380140800008
Scopus-id: 2-s2.0-84962135605
| 21 | 23 |
| 14 | Surgical reintervention in acromegaly: Is it still worth trying? | Coautor: Sosa E., De Los Monteros A.L.E., González B., Vargas G., et al. | 2009 | ENDOCRINE PRACTICE | WoS-id: 000268923600005
Scopus-id: 2-s2.0-70449731062
| 8 | 12 |
| 15 | Biochemical evaluation of disease activity after pituitary surgery in acromegaly: A critical analysis of patients who spontaneously change disease status | 2ᵒ autor: Sosa E., Espinosa-De-Los-Monteros A.L., Cheng S., Ochoa R., et al. | 2006 | CLINICAL ENDOCRINOLOGY | WoS-id: 000235355200003
Scopus-id: 2-s2.0-33644957309
| 39 | 46 |
| 16 | GSPa mutations in Mexican patients with acromegaly: Potential impact on long term prognosis | 2ᵒ autor: Sosa E., Mendoza V., Espinosa-de-los-Monteros A.L., Salcedo M., et al. | 2005 | GROWTH HORMONE & IGF RESEARCH | WoS-id: 000227250400004
Scopus-id: 2-s2.0-13544272837
| 28 | 29 |
| 17 | Clinical-biochemical correlations in acromegaly at diagnosis and the real prevalence of biochemically discordant disease | Coautor: Sosa E., Mercado M., Espinosa De Los Monteros A.L., Cheng S., et al. | 2004 | HORM RES | WoS-id: 000226114300006
Scopus-id: 2-s2.0-11244329010
| 44 | 49 |
| 18 | Changing patterns of insulin-like growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly | Coautor: Sosa E., Espinosa-de-los-Monteros A.L., Mercado M., Lizama O., et al. | 2002 | JOURNAL OF NEUROSURGERY | WoS-id: 000177352700008
Scopus-id: 2-s2.0-0036320419
| 36 | 37 |
| 19 | High biochemical recurrence rate after withdrawal of cabergoline in prolactinomas: is it necessary to restart treatment? | Coautor: Sosa-Eroza E., Espinosa-Cárdenas E., Sánchez-García M., Ramírez-Rentería C., et al. | | ENDOCRINE | WoS-id: 000540676500001
Scopus-id: 2-s2.0-85087086711
| 13 | 15 |
ID's SCOPUS 